XML 23 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,755) $ (3,995)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 461 130
Stock-based compensation to employees, directors and non-employees consultants 1,176 1,063
Stock compensation to investor relations consultants    273
Increase in other accounts receivable (2,150) (746)
Increase in prepaid expenses (7) (483)
Decrease (increase) in trade payables 247 988
Increase in other accounts payable and accrued expenses 160 30
Increase (decrease) in deferred revenues (474) (195)
Increase (decrease) in advance payment from United Therapeutics (37) (617)
Linkage differences and Increase (decrease) interest on short and long-term deposit and restricted lease deposit (168) (37)
Accretion of discount, amortization of premium and changes in accrued interest from marketable securities 559 43
Loss (gain) from sale of investments of available for sale marketable securities (142) 15
Accrued severance pay, net 35 9
Net cash used in operating activities (5,095) (3,522)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (462) (1,978)
Repayment in short-term deposits 7,132   
Repayment (investment) in long-term deposits (3) 300
Repayment of long-term restricted deposit 112 3
Proceeds from sale of available-for-sale marketable securities 1,870 313
Proceeds from redemption of available-for-sale marketable securities 394   
Investment in available-for-sale marketable securities (4,861) (1,248)
Net cash provided by (used in) investing activities 4,182 (2,610)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Issuance of common stock and warrants, net of issuance costs    34,106
Exercise of options and warrants 509 1,388
Net cash provided by financing activities 509 35,494
Increase (decrease) in cash and cash equivalents (404) 29,362
Cash and cash equivalents at the beginning of the period 9,007 9,389
Cash and cash equivalents at the end of the period 8,603 38,751
(a) Supplemental disclosure of cash flow activities:    
Cash paid during the period for taxes due to non-deductible expenses 31 3
(b) Supplemental disclosure of non-cash activities:    
Purchase of property and equipment on credit 668 78
Stock based compensation to contractor    $ 1,400